HomeALXO • NASDAQ
add
ALX Oncology Holdings Inc
Previous close
$2.02
Day range
$1.97 - $2.04
Year range
$0.41 - $2.66
Market cap
261.24M USD
Avg Volume
929.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.02M | -24.80% |
Net income | -22.85M | 21.65% |
Net profit margin | — | — |
Earnings per share | -0.37 | 15.99% |
EBITDA | -22.87M | 24.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.79M | -64.94% |
Total assets | 59.05M | -60.04% |
Total liabilities | 33.06M | -3.20% |
Total equity | 25.98M | — |
Shares outstanding | 131.61M | — |
Price to book | 4.21 | — |
Return on assets | -81.19% | — |
Return on capital | -113.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -22.85M | 21.65% |
Cash from operations | -18.98M | 40.77% |
Cash from investing | 11.23M | -66.15% |
Cash from financing | 678.00K | 106.71% |
Net change in cash | -7.07M | -582.53% |
Free cash flow | -15.76M | 36.95% |
About
Founded
2015
Headquarters
Website
Employees
43
